|
Real-time Estimate
Cboe BZX
00:57:00 07/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 174.16 USD | +11.04% |
|
+19.23% | +66.48% |
| 08:24pm | Oppenheimer Adjusts Palvella Therapeutics Price Target to $232 From $210, Maintains Outperform Rating | MT |
| 11-05 | Palvella Therapeutics Shares Drop After Q3 Net Loss Widens | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +11.04% | +19.23% | +36.13% | +12.47% | +66.48% | +121.61% | - | - | - | 2.26B | |
| -4.83% | +2.88% | -12.15% | -0.34% | +62.18% | +55.87% | +69.12% | +16.30% | - | 69.4B | |
| +0.02% | +1.07% | -2.28% | +8.22% | +13.81% | +10.63% | +76.66% | +198.17% | +6,189.90% | 57.24B | |
| -1.34% | +2.98% | +15.13% | +17.08% | +23.35% | +24.79% | +100.18% | -7.19% | +267.33% | 57.62B | |
| +2.69% | +2.28% | +5.17% | +17.64% | +21.30% | +29.67% | +37.82% | +8.72% | +266.57% | 43.65B | |
| +5.15% | +10.45% | +12.75% | +24.02% | +34.63% | +23.07% | +108.54% | +16.92% | +1,180.60% | 44.03B | |
| +8.61% | +1.75% | -2.61% | -1.59% | +144.39% | +217.14% | +803.71% | +494.74% | - | 38.08B | |
| -1.86% | +11.46% | +15.55% | +10.88% | +22.40% | +26.67% | +61.40% | +22.80% | +180.36% | 36.31B | |
| -2.97% | -9.84% | +42.10% | +87.91% | +74.00% | +88.86% | +76.17% | +17.18% | +196.64% | 32.61B | |
| -2.18% | +5.68% | -14.04% | +17.23% | +51.46% | +36.21% | -0.69% | -53.27% | - | 25.47B | |
| +5.37% | +0.66% | +7.69% | -14.50% | -34.89% | -38.97% | +375.36% | +245.19% | +862.83% | 23.86B | |
| +1.68% | -0.48% | -8.34% | -3.77% | -7.83% | -15.09% | -11.99% | -63.83% | - | 21.29B | |
| +2.99% | +0.43% | +8.61% | +11.93% | +16.58% | +10.57% | +143.08% | +191.59% | +1,964.28% | 17.76B | |
| +1.34% | +0.59% | +19.66% | +33.72% | +59.25% | +71.08% | +234.93% | +272.07% | +464.72% | 16.77B | |
| -0.45% | +1.05% | +16.42% | +26.85% | +42.05% | +51.21% | +74.63% | -13.29% | +120.47% | 17.35B | |
| +1.48% | +2.47% | +13.90% | +3.05% | - | - | - | - | - | 16.64B | |
| +7.17% | +2.42% | +6.72% | -4.87% | +199.74% | +184.32% | +358.47% | +1,547.39% | +865.04% | 14.86B | |
| +7.77% | -5.53% | +11.34% | +27.89% | +70.22% | +98.71% | +87.21% | -9.18% | +383.07% | 15B | |
| +1.44% | -3.38% | +26.30% | +26.71% | +12.07% | +27.64% | -20.81% | -23.81% | +166.43% | 15.11B | |
| +8.08% | +6.23% | +6.59% | +66.35% | +29.92% | +6.42% | - | - | - | 12.85B | |
| Average | +2.49% | -0.43% | +10.23% | +18.34% | +47.43% | +54.23% | +151.40% | +168.26% | +1,008.33% | 28.91B | |
| Weighted average by Cap. | +1.11% | +0.83% | +6.93% | +16.25% | +43.99% | +48.61% | +145.46% | +122.21% | +1,358.52% |
- Stock Market
- Stocks
- PVLA Stock
- Sector Palvella Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
